Skip to main content

Table 1 Effects of bezafibrate, quinazolinone and its halogenated derivatives on relative liver weights of rats with single and combined hypercholesterolemia compared to normal controls.

From: The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in rats

Single Hypercholesterolemia Combined Hypercholesterolemia
Groups Liver wt./b.wt. Groups Liver wt./b.wt.
N.C   N.C  
Mean ± SD 0.031 ± 0.005 Mean ± SD 0.031 ± 0.005
Range (0.024–0.039) Range (0.024–0.039)
HCD+B   C+B  
Mean ± SD 0.030 ± 0.003 Mean ± SD 0.037 ± 0.005
Range (0.025–0.032) Range (0.032–0.045)
Change% -11.76 Change% 5.71
HCD+Q   C+Q  
Mean ± SD 0.033 ± 0.003 Mean ± SD 0.030 ± 0.002
Range (0.029–0.037) Range (0.028–0.033)
Change% -2.94 Change% -14.29
HCD+BrQ   C+BrQ  
Mean ± SD 0.031 ± 0.003 Mean ± SD 0.029 ± 0.003
Range (0.028–0.035) Range (0.025–0.036)
Change% -8.82 Change% -17.14
HCD+IQ   C+IQ  
Mean ± SD 0.030 ± 0.002 Mean ± SD 0.030 ± 0.001
Range (0.027–0.032) Range (0.027–0.031)
Change% -11.76 Change% -14.29